Sec. 202. Grant program to reduce drug overdose deaths
662 words·~3 min read·
/bill/114/s/2562/is/section-202·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Secretary of Health and Human Services, acting through the Administrator of the Substance Abuse and Mental Health Services Administration, shall award grants or enter into cooperative agreements with eligible entities to enable the eligible entities to reduce deaths occurring from overdoses of drugs. To be eligible to receive a grant or cooperative agreement under this section, an entity shall be a partnership between any of the following: a State, local, or tribal government, a correctional institution, a law enforcement agency, a community agency, a professional organization in the field of poison control and surveillance, or a private nonprofit organization.
An eligible entity desiring a grant or cooperative agreement under this section shall submit to the Secretary of Health and Human Services an application at such time, in such manner, and containing such information as the Secretary may require. An application under paragraph
(1)shall include— a description of the activities to be funded through the grant or cooperative agreement; and evidence that the eligible entity has the capacity to carry out such activities. In entering into grants and cooperative agreements under subsection (a), the Secretary of Health and Human Services shall give priority to eligible entities that— include a public health agency or community-based organization; and have expertise in preventing deaths occurring from overdoses of drugs in populations at high risk of such deaths. As a condition of receipt of a grant or cooperative agreement under this section, an eligible entity shall agree to use the grant or cooperative agreement to do each of the following: Purchase and distribute the drug naloxone or a similarly effective medication. Carry out one or more of the following activities: Educating prescribers and pharmacists about overdose prevention and naloxone prescription, or prescriptions of a similarly effective medication. Training first responders, other individuals in a position to respond to an overdose, and law enforcement and corrections officials on the effective response to individuals who have overdosed on drugs. Training pursuant to this subparagraph may include any activity that is educational, instructional, or consultative in nature, and may include volunteer training, awareness building exercises, outreach to individuals who are at risk of a drug overdose, and distribution of educational materials. Implementing and enhancing programs to provide overdose prevention, recognition, treatment, and response to individuals in need of such services. Educating the public and providing outreach to the public about overdose prevention and naloxone prescriptions, or prescriptions of other similarly effective medications. The Secretary of Health and Human Services shall establish and provide for the operation of a coordinating center responsible for— collecting, compiling, and disseminating data on the programs and activities under this section, including tracking and evaluating the distribution and use of naloxone and other similarly effective medication; evaluating such data and, based on such evaluation, developing best practices for preventing deaths occurring from drug overdoses; making such best practices specific to the type of community involved; coordinating and harmonizing data collection measures; evaluating the effects of the program on overdose rates; and education and outreach to the public about overdose prevention and prescription of naloxone and other similarly effective medication. As a condition on receipt of a grant or cooperative agreement under this section, an eligible entity shall agree to prepare and submit, not later than 90 days after the end of the award period, a report to such coordinating center and the Secretary of Health and Human Services describing the results of the activities supported through the grant or cooperative agreement. The period of a grant or cooperative agreement under this section shall be 4 years. In this part, the term drug — means a drug, as defined in section 201 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321 ); and includes controlled substances, as defined in section 102 of the Controlled Substances Act ( 21 U.S.C. 802 ). There is authorized to be appropriated $20,000,000 to carry out this section for each of the fiscal years 2017 through 2021.
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources